220 related articles for article (PubMed ID: 17690594)
21. The long term--maximising potential for rehabilitation in patients with schizophrenia.
Fagiolini A; Goracci A
Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S123-9. PubMed ID: 17336767
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of acute and chronic psychoses in childhood and adolescence].
Eggers Ch
MMW Fortschr Med; 2005 Dec; 147(48):41, 43-5. PubMed ID: 16389861
[TBL] [Abstract][Full Text] [Related]
24. Clinical effectiveness in first-episode patients.
Ohlsen RI; O'Toole MS; Purvis RG; Walters JT; Taylor TM; Jones HM; Pilowsky LS
Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S445-51. PubMed ID: 15572263
[TBL] [Abstract][Full Text] [Related]
25. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
26. Developing an outcomes-oriented approach for the treatment of schizophrenia.
Lehman AF
J Clin Psychiatry; 1999; 60 Suppl 19():30-5; discussion 36-7. PubMed ID: 10507278
[TBL] [Abstract][Full Text] [Related]
27. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
Gibel A; Ritsner MS
Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
[TBL] [Abstract][Full Text] [Related]
28. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
29. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
30. [Early detection of schizophrenic psychoses].
Lauber C; Rössler W
Praxis (Bern 1994); 2001 May; 90(22):987-92. PubMed ID: 11450187
[TBL] [Abstract][Full Text] [Related]
31. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
32. A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Salimi S; Fotouhi A; Ghoreishi A; Derakhshan MK; Khodaie-Ardakani MR; Mohammadi MR; Noorbala AA; Ahmadi-Abhari SA; Hajiazim M; Abbasi SH; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):726-32. PubMed ID: 18096287
[TBL] [Abstract][Full Text] [Related]
33. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
[TBL] [Abstract][Full Text] [Related]
34. Negative symptoms of schizophrenia: a problem that will not go away.
Stahl SM; Buckley PF
Acta Psychiatr Scand; 2007 Jan; 115(1):4-11. PubMed ID: 17201860
[TBL] [Abstract][Full Text] [Related]
35. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
[TBL] [Abstract][Full Text] [Related]
36. Long-term phase of schizophrenia: impact of atypical agents.
Naber D
Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S11-4. PubMed ID: 11252518
[TBL] [Abstract][Full Text] [Related]
37. Long-term diagnostic stability and outcome in recent first-episode cohort studies of schizophrenia.
Bromet EJ; Naz B; Fochtmann LJ; Carlson GA; Tanenberg-Karant M
Schizophr Bull; 2005 Jul; 31(3):639-49. PubMed ID: 15976012
[TBL] [Abstract][Full Text] [Related]
38. Sociodemographic and clinical factors associated with relapse in schizophrenia.
Chabungbam G; Avasthi A; Sharan P
Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic safety and efficacy concerns.
Meyer JM
J Clin Psychiatry; 2007; 68 Suppl 14():20-6. PubMed ID: 18284274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
